• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS COAGUCHEK XS PT TEST; PROTHROMBIN TIME TEST STRIPS Back to Search Results
Model Number N
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/23/2022
Event Type  malfunction  
Manufacturer Narrative
The customer's meter and test strips were requested for investigation.The returned test strips were measured in comparison with the current test strip master lot.For this purpose, two human blood samples from marcumar donors and internal reference meters were used.Marcumar donor 1 hematocrit = 44 %; marcumar donor 2 hematocrit = 37 %.Testing results: marcumar donor 1 with master lot strips = 2.4 inr; marcumar donor 1 with returned strips = 2.5 inr; marcumar donor 2 with master lot strips = 2.0 inr; marcumar donor 2 with returned strips = 2.0 inr.All inr values were within the specified target ranges, confirming the functionality of the coaguchek measuring system.No error messages occurred.On a regular basis, coaguchek strips of lots currently valid in the market are tested as part of routine retention testing and results have passed the internal inspection.Per product labeling: "coaguchek uses human recombinant thromboplastin.Therefore, the comparability to other human recombinant thromboplastins is best, whereas higher deviations can occur with other thromboplastins.However, those higher differences between thromboplastins of different (rabbit, bovine based) origin are not a coaguchek specific issue.Similar differences can be observed when a human recombinant thromboplastin-based laboratory method is compared against several other (rabbit, bovine-based) laboratory methods." upon review of the meter's patient result memory, the following were the only values listed for (b)(6) 2022: 2.4 inr at 06:13 on (b)(6) 2022; 2.2 inr at 06:15 on (b)(6) 2022.
 
Event Description
It was alleged that a patient received questionable results when testing with coaguchek xs meter serial number (b)(4).It was alleged that the patient performed back-to-back tests on the meter at 7:30 a.M.On (b)(6) 2022, resulting in values of 2.4 inr and 2.0 inr respectively.It was reported that at 17:00 on the same day, a sample from the patient was tested on the meter, resulting in a value of 2.1 inr.It was alleged that at 10:00 a.M.On (b)(6) 2022, a sample from the patient was tested in the laboratory using an unknown method, resulting in a value of 1.9 inr.The patient is reported to have a therapeutic range of 2.0 - 3.0 inr.The patient reportedly measures with the meter 1-2 times a month.
 
Manufacturer Narrative
The component, evaluation method, evaluation result, and evaluation conclusion codes have been updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COAGUCHEK XS PT TEST
Type of Device
PROTHROMBIN TIME TEST STRIPS
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key16022883
MDR Text Key308392384
Report Number1823260-2022-04133
Device Sequence Number1
Product Code GJS
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K062925
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Consumer
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 12/29/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/21/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date01/31/2023
Device Model NumberN
Device Catalogue Number04625315016
Device Lot Number55343013
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/01/2022
Is the Reporter a Health Professional? No
Date Manufacturer Received12/22/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
GABAPENTIN; HEPARIN; L-THYROXINE; MARCUMAR
Patient Age47 YR
Patient SexFemale
-
-